The hospital contributes to the collection of material from breast cancer patients to the OSLO2 study. The hospital is also involved in the recruitment of patients to other clinical trials.

Group leader Olaf-Johan Hartman-Johnsen, MD, PhD, Østfold Hospital Trust.